To accelerate and de-risk drug development, Gerresheimer AG and Nelson Labs NV announce a formal strategic partnership on analytical and drug compatibility lab testing for the pharmaceutical and biotech industries.
Piet Christiaens, scientific director, Nelson Labs said,“I am extremely pleased that Gerresheimer and Nelson Labs have taken this very important step forward in joining our forces to provide customers with stellar testing and expert advice in container/closure qualification. From the initial discussions of the partnership, it was clear that both companies share the same values when it comes to service-oriented customer support. This strategic partnership will allow Nelson Labs to further expand our position in the vibrant and rapidly developing Asia Pacific Region.”
Stefan Verheyden, global VP, Gx biological solutions said, “Thanks to this partnership with Nelson Labs, and its proven track record in the fields of container closure integrity (CCI) and E&L, we at Gerresheimer have become one of the world’s leading partners of the pharmaceutical and healthcare industries. Our broad portfolio includes many pharmaceutical packaging products and safe drug delivery systems such as insulin pens, inhalers, prefilled syringes, vials, cartridges, and bottles and containers for liquid and solid drugs with closure and safety systems.”
